| Literature DB >> 28856325 |
T Mehta1, R Dey1, A Chaudhuri1.
Abstract
INTRODUCTION: A 75-year-old male patient with significant cardiopulmonary comorbidity presented with a 70-mm left femoral pseudoaneurysm 6 years after aortobifemoral bypass (and prior femoral endarterectomy). REPORT: As the left superficial femoral artery was occluded, an ilioprofunda endobypass was undertaken following extraperitoneal exposure of the left limb of the bypass graft with subsequent deployment of four Viabahn endoprostheses via the left limb into the proximal left deep femoral artery with successful exclusion of the pseudoaneurysm. The endografts remain patent at 6 months with regression noted in the pseudoaneurysm itself. DISCUSSION: Post-operative femoral pseudoaneurysm following anastomotic dehiscence has traditionally been treated by open surgical repair. Re-re-do open femoral vascular surgery has a high complication rate. Scarring and potential graft infection may necessitate ligation of involved arteries and extra-anatomic bypasses with an attendant risk of limb loss. Although the common femoral artery is conventionally contraindicated for endograft deployment because of the perceived high risk of stent fracture in a highly mobile zone, an endobypass can avoid the potential complications of open revision groin surgery in an unfit, high-risk patient.Entities:
Keywords: Endobypass; Femoral artery; Pseudoaneurysm; Stent-graft
Year: 2016 PMID: 28856325 PMCID: PMC5576153 DOI: 10.1016/j.ejvssr.2016.11.001
Source DB: PubMed Journal: EJVES Short Rep ISSN: 2405-6553
Figure 1CTA indicating the 70 mm left femoral pseudoaneurysm.
Figure 2(A) Angiogram indicating the pseudoaneurysm and the outflow via the DFA. (B) Screenshot of the four endoprostheses after deployment. (C) Completion angiogram indicates successful pseudoaneurysm exclusion and PFA outflow with proximal branch preservation (arrow = transition zone from CFA to DFA).
Figure 3Post-procedure CTA (right anterior oblique perspective) indicating good position of the endoprostheses with no endoleaks noted.